KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.915 16 days ( 11.08 % )
Last Price $0.92 3.67 %
High/ Low $0.87 - $0.92 6.76%
Chg 7 Days 0.648 % $0.91 $0.92
Chg 30 Days -27.88 % $1.27 $0.92
Chg 12 mos -77.82 % $4.13 $0.92
Trend - 3 mos 9.67 % Width: 82.24 %
Trend - 12 mos -88.28 % Width: 152.49 %
Pred. range - 3 mos $0.86 - $1.57 -6.11 % - 71.11 %
Pred. range - 12 mos N/A - $0.0857 -100.00 % - -90.65 %
Short MA avg 3 mos Sell Apr 19, 2024 - 5 days
Long MA avg 3 mos Sell Apr 01, 2024 - 19 days
Short/Long MA avg 3 mos Sell Apr 05, 2024 - 15 days
Short MA avg 12 mos Sell Mar 28, 2024 - 20 days
Long MA avg 12 mos Sell Apr 19, 2024 - 5 days
Short/Long MA avg 12 mos Buy Mar 12, 2024 - 32 days
Pivot Short Sell Mar 14, 2024 - 30 days
Bollinger Buy Dec 18, 2023 - 89 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Durect Corporation

Durect DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in... DRRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT